Formatado: Fonte: Negrito
Referências Bibliográficas
1. Barros, Sérgio G. S. de. Doença do refluxo gastroesofágico – prevalência,
fatores de risco e desafios... Arq Gastroenterol. 2005;42 (2); 71
2. Oliveira SS, Santos IS, Silva JFP, Machado EC. Prevalência e fatores associados
à doença de refluxo gastroesofágico. Arq Gastroenterol, 2005; 42(2)
3. Chinzon D, Rossini ARA, Kiburd B, Navarro-Rodrigues T, Barbuti RC,
Hashimoto CL, Eisig JN, Moraes-Filho JPP. Refluxo Gastroesofágico:
diagnóstico e tratamento. Projeto Diretrizes - Associação Médica Brasileira,
2003.
4. Goodman & Gilman. As Bases Farmacológicas da Terapêutica. 10 Ed. Editora
McGrallHill, 2005; 757-69.
5. Fiss E, Mott CB, Chizon D, Rodrigues TN, Moraes Filho JP, Curr A et al.
Asthma induced by instillation of clorid acid in the oesophagus. Chest, 1994;
106:147S.
6. Edwards SJ, Lind T, Lundell L. Systematic review of proton pump inhibitors for
the acute treatment of reflux oesophagitis. Aliment Pharmacol Ther. 2001
Nov;15(11):1729-36.
7. Edwards SJ, Lind T, Lundell L.Systematic review: proton pump inhibitors
(PPIs) for the healing of reflux oesophagitis - a comparison of esomeprazole
with other PPIs. Aliment Pharmacol Ther. 2006 Sep 1;24(5):743-50.
8. KlokR M, PostmaM J, HoutB A, BrouwersJ R, Meta-analysis: comparing the
efficacy of proton pump inhibitors in short-term use. Alimentary Pharmacology
and Therapeutics 2003;17(10) :1237-1245.
9. Thjodleifsson B, Rindi G, Fiocca R, et al: A randomized, double-blind trial of
the efficacy and safety of 10 or 20 mg rabeprazole compared with 20 mg
omeprazole in the maintenance of gastro-oesophageal reflux disease over 5
years. Aliment Pharmacol Ther 2003; 17(3):343-351.
10. Dekkers CPM, Beker JA, Thjodleifsson B, et al: Double-blind, placebocontrolled comparison of rabeprazole 20 mg vs. omeprazole 20 mg in the
treatment of erosive or ulcerative gastro-esophageal reflux disease. Aliment
Pharmacol Ther 1999; 13:49-57.
11. Holtmann G, Bytzer P, Metz M, Loeffler V, Blum AL. A randomized, doubleblind, comparative study of standard-dose rabeprazole and high-dose
omeprazole in gastro-oesophageal reflux disease. Aliment Pharmacol Ther,
2002; 16(3): 479-85.
12. Jaspersen D, Diehl K-L, Schoeppner H, et al: A comparison of omeprazole,
lansoprazole and pantoprazole in the maintenance treatment of severe reflux
oesophagitis. Aliment Pharmacol Ther 1998; 12:49-52.
13. Mulder CJJ, Westerveld BD, Smit JM, et al: A double-blind, randomized
comparision of omeprazole multiple unit pellet system (MUPS) 20 mg,
lansoprazole 30 mg and pantoprazole 40 mg in symptomatic reflux oesophagitis
followed by 3 months of omeprazole MUPS maintenance treatment: a Dutch
multicentre trial. Eur J Gastroenterol Hepatol 2002; 14:649-656.
Formatado: Centralizado